corresp

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FW4hfoj3Su5ISrrwa+0XfefliCF1lj3954ZiFotuyDKokgmhryISZhkKtpuxTz2X nerT9zKdk2O6kihUueYzAw== 0000950134-07-020197.txt : 20080310 0000950134-07-020197.hdr.sgml : 20080310 20070919195359 ACCESSION NUMBER: 0000950134-07-020197 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070919 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENENTECH INC CENTRAL INDEX KEY: 0000318771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942347624 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1 DNA WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-225-1000 MAIL ADDRESS: STREET 1: 1 DNA WAY STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 CORRESP 1 filename1.htm corresp

September 19, 2007

VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Michael Reedich, Special Counsel

Re:

Genentech, Inc.
Definitive 14A
Filed March 16, 2007
File No. 1-09813

Ladies and Gentlemen:

We refer to Mr. Reedich’s letter dated August 21, 2007 which sets forth the comments of the staff of the Securities and Exchange Commission (the “Staff”) regarding the Definitive 14A filing on March 16, 2007 of Genentech, Inc. (the “Company”). The Company hereby requests additional time to respond to the Staff’s comments. The Company intends to respond to the Staff’s comments by October 5, 2007.

If you have any questions, please do not hesitate to call Michael Snyder at (650) 467-8815 or me at (650) 225-3562.


	Sincerely,
	/s/ Sean A. Johnston
	Sean A. Johnston
	Senior Vice President and General Counsel Genentech, Inc.

-----END PRIVACY-ENHANCED MESSAGE-----